Anuj Bhargava
Endocrinology, Diabetes & Metabolism · Des Moines, IANPI 1669563052
Payments from drug & device makers
Across 3,486 payments — averaging $5831.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly$8.9M
- Medtronic$2.7M
- Dexcom, Inc.$2.5M
- Abbott$2.4M
- Novo Nordisk AS$1.1M
- AbbVie$745K
- plus $2M from 24 others
Across 36 payments — averaging $5862.66 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$210K
- Mannkind Corporation$605
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly | 311 | $8,881,106 |
| Medtronic(2 entities) | 174 | $2,724,947 |
| Dexcom, Inc. | 144 | $2,461,682 |
| Abbott | 434 | $2,406,520 |
| Novo Nordisk AS | 1,717 | $1,065,044 |
| AbbVie | 102 | $745,389 |
| Sanofi US Services Inc. | 91 | $540,535 |
| Boehringer Ingelheim | 41 | $534,301 |
| Mannkind Corporation | 57 | $278,049 |
| Insulet Corporation | 26 | $209,244 |
| Sequel Med Tech, LLC | 157 | $170,629 |
| Pfizer | 30 | $126,292 |
| Kowa Research Institute, Inc. | 35 | $65,059 |
| Madrigal Pharmaceuticals | 12 | $26,822 |
| GSK | 1 | $25,771 |
| Boehringer Ingelheim International GmbH | 106 | $19,649 |
| AstraZeneca | 5 | $18,499 |
| Lexicon Pharmaceuticals, Inc. | 2 | $10,304 |
| Merck | 8 | $7,497 |
| Sanofi-aventis U.S. LLC | 10 | $6,153 |
| Bayer | 6 | $3,500 |
| Novartis | 2 | $209 |
| Ascensia Diabetes Care US Inc. | 4 | $175 |
| Janssen Scientific Affairs, LLC | 1 | $123 |
| Novo Nordisk | 3 | $103 |
| Lilly USA, LLC | 3 | $32 |
| Tandem Diabetes Care, Inc. | 1 | $25 |
| BETA Bionics, Inc. | 1 | $24 |
| Zealand Pharma US, Inc. | 1 | $16 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
How this compares
$20,327,715 in reported general payments places this provider in the 95th percentile of 38 endocrinology, diabetes & metabolism providers in Iowa.
See all endocrinology, diabetes & metabolism providers in Iowa →
Other endocrinology, diabetes & metabolism in Des Moines
- Teck KhooDes Moines$6K
- Vanitha SingaramDes Moines$824
- Pierre TheumaDes Moines$681
- Gurbir GillDes Moines$480
- Pearl DyDes Moines$430
- Daniela MilaniDes Moines$296
- Marcelo CorreiaIowa City$1.5M
- Joseph DillonIowa City$241K
- Ayotunde DokunIowa City$218K
- Mary FigaroDavenport$73K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.